We caught up with Mather, who participated in the game changer session The Risks and Rewards of GLP-1 Agonists Beyond Diabetes at the 2025 American Physiology Summit in April
Some studies indicate that GLP-1s improve mood and mental health, while others suggest an elevated risk of depression and anxiety
Eli Lilly remains confident in their market position, though, stating Novo will be competing with other, non-oral diabetes treatments , such as Jardiance and Mercks Steglatro
"Amphetamine Tannate
BPC-157 takes a broader approach, activating VEGFR2 receptors, suppressing inflammatory cytokines, and boosting fibroblast growth to heal scalp tissue and improve nutrient delivery
Other moms-to-be might experience hyper-sensitivity to skincare depending on how the body responds to pregnancy hormones